ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - coagulation factor ix recombinant-rfix - אבקה מיובשת בהקפאה להזרקה - coagulation factor ix recombinant-rfix 250 iu/vial - coagulation factor ix - coagulation factor ix - benefix is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia b (congenital factor ix deficiency or christmas disease), including control and prevention of bleeding in surgical settings, in previously treated patients (ptp) and previously untreated patients (pup). benefix is not indicated for the treatment of other factor deficiencies (e.g. factors ii,vii, and x)' nor for the treatment of hemophilia a patients with inhibitors to factor viii, nor for the reversal of coumarin-induced anticoagulation, nor for the treatment of bleeding due to low levels of liver-dependent coagulation factors.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - coagulation factor ix recombinant-rfix - אבקה מיובשת בהקפאה להזרקה - coagulation factor ix recombinant-rfix 500 iu/vial - coagulation factor ix - coagulation factor ix - benefix is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia b (congenital factor ix deficiency or christmas disease), including control and prevention of bleeding in surgical settings, in previously treated patients (ptp) and previously untreated patients (pup).benefix is not indicated for the treatment of other factor deficiencies (e.g. factors ii,vii, and x)' nor for the treatment of hemophilia a patients with inhibitors to factor viii, nor for the reversal of coumarin-induced anticoagulation, nor for the treatment of bleeding due to low levels of liver-dependent coagulation factors.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - coagulation factor ix recombinant-rfix - אבקה מיובשת בהקפאה להזרקה - coagulation factor ix recombinant-rfix 1000 iu/vial - coagulation factor ix - coagulation factor ix - benefix is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia b (congenital factor ix deficiency or christmas disease), including control and prevention of bleeding in surgical settings, in previously treated patients (ptp) and previously untreated patients (pup). benefix is not indicated for the treatment of other factor deficiencies (e.g. factors ii,vii, and x)' nor for the treatment of hemophilia a patients with inhibitors to factor viii, nor for the reversal of coumarin-induced anticoagulation, nor for the treatment of bleeding due to low levels of liver-dependent coagulation factors.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - coagulation factor ix recombinant-rfix - אבקה מיובשת בהקפאה להזרקה - coagulation factor ix recombinant-rfix 2000 iu - coagulation factor ix - coagulation factor ix - benefix is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia b (congenital factor ix deficiency or christmas disease), including control and prevention of bleeding in surgical settings, in previously treated patients (ptp) and previously untreated patients (pup). benefix is not indicated for the treatment of other factor deficiencies (e.g. factors ii,vii, and x)' nor for the treatment of hemophilia a patients with inhibitors to factor viii, nor for the reversal of coumarin-induced anticoagulation, nor for the treatment of bleeding due to low levels of liver-dependent coagulation factors.

ישראל - עברית - Ministry of Health

ben shimon floris ltd, israel - benzoic acid; salicylic acid - תמיסה כוהלית - benzoic acid 6 %w/v; salicylic acid 3 %w/v - salicylic acid - salicylic acid - antifungal, antiseptic.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - benzoic acid; salicylic acid; tolnaftate - משחה - tolnaftate 10 mg/g; benzoic acid 60 mg/g; salicylic acid 30 mg/g - salicylic acid - salicylic acid - superficial dermatomycosis where a keratolytic effect is also required

ישראל - עברית - Ministry of Health

rekah pharmaceutical industry ltd, israel - benzoic acid; lidocaine as hydrochloride; salicylic acid - תמיסה - benzoic acid 6 %; salicylic acid 3 %; lidocaine as hydrochloride 1 % - combinations - combinations - for antifungal treatment.

ישראל - עברית - Ministry of Health

rekah pharmaceutical industry ltd, israel - benzoic acid as sodium; codeine phosphate; ephedrine hydrochloride; guaiacolsulfonate as potassium - סירופ - benzoic acid as sodium 20 mg / 5 ml; ephedrine hydrochloride 6 mg / 5 ml; guaiacolsulfonate as potassium 125 mg / 5 ml; codeine phosphate 2 mg / 5 ml - opium alkaloids and derivatives - for relief of cough.

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - benzoic acid as sodium; dextromethorphan hydrobromide; ephedrine hydrochloride; guaiacolsulfonate as potassium - סירופ - ephedrine hydrochloride 1.2 mg/ml; dextromethorphan hydrobromide 1 mg/ml; guaiacolsulfonate as potassium 24 mg/ml; benzoic acid as sodium 4 mg/ml - combinations - combinations - relief of cough.

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - benzoic acid as sodium; guaiacolsulfonate as potassium; oxomemazine - סירופ - oxomemazine 1.65 mg / 5 ml; benzoic acid as sodium 33.3 mg / 5 ml; guaiacolsulfonate as potassium 33.3 mg / 5 ml - oxomemazine - oxomemazine - antitussive expectorant.